SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Aug. 29, 2006--Fluidigm Corporation has announced that its Singapore-based manufacturing facility has ramped up to full process R&D and manufacturing operations, less than a year after opening its doors. The rapid startup boosts the Company’s entry into the billion dollar real-time qPCR market, enabling production of BioMark(TM) dynamic arrays to supply high-end users. These unique biochips increase qPCR efficiency by orders of magnitude and may replace microwell plates as the industry standard of the future.
